Abigail Brooks

Bayville

Assistant Editor at HCP Live

Featured in: Favicon

hcplive.com Favicon

mjhlifesciences.com Favicon

outlooknews.co.uk Favicon

einnews.com Favicon

monmouth.edu Favicon

contagionlive.com Favicon

ajmc.com

contemporaryobgyn.net Favicon

contemporarypediatrics.com Favicon

newsrnd.com + 3 more

Articles

Depression Linked to Poor Cardiovascular Outcomes in Spontaneous Coronary Artery Dissection

2 weeks ago | hcplive.com | Abigail Brooks

Comorbid depression in patients with spontaneous coronary artery dissection (SCAD) is linked to a significantly increased risk of several adverse cardiovascular outcomes, according to findings from a recent study.1 The data were presented at the 9th Annual Heart in Diabetes Conference in Philadelphia, Pennsylvania, by Abena Korwaa Agyekum, MD, an internal medicine resident at SUNY Downstate, and suggest depression screening should be incorporated into routine SCAD care to improve outcomes.1...
Obicetrapib Reduces HbA1c, New-Onset Diabetes Risk in ASCVD, HeFH

2 weeks ago | hcplive.com | Abigail Brooks

New research is shedding light on the impact of treatment with obicetrapib on HbA1c and new-onset diabetes risk in patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) and prediabetes or normoglycemia on a background of mostly high-intensity statins.1 The pooled analysis of data from the phase 3 BROOKLYN and BROADWAY trials was led by Stephen Nicholls, MBBS, PhD, director of the Monash Victorian Heart Institute and professor of...
Cardiac Catheterization After Positive Stress Test Improves Post-Kidney Transplant Survival

3 weeks ago | hcplive.com | Abigail Brooks

New research is shedding light on the potential benefits of cardiac catheterization following a positive stress test for improving survival in kidney transplant recipients.1 The data were presented at the 9th Annual Heart in Diabetes Conference in Philadelphia, Pennsylvania, by Sudhanvan Iyer, BSA, of John Sealy School of Medicine at the University of Texas Medical Branch, and suggest the potential value of cardiac catheterization as a targeted intervention in pretransplant cardiac risk...
Women with Premature Menopause Face Greater Cardiovascular Risks, Study Finds

3 weeks ago | hcplive.com | Abigail Brooks

New research is shedding light on a significant association between premature menopause and increased cardiovascular disease risk.1The data were presented at the 9th Annual Heart in Diabetes Conference by Abena Korwaa Agyekum, MD, an internal medicine resident at SUNY Downstate, and suggest the importance of cardiovascular risk assessment and prevention in this patient population.1According to the OASH Office on Women’s Health, the average age for menopause in the United States is 52.
Hepatology Month in Review: May 2025

3 weeks ago | hcplive.com | Abigail Brooks

May proved to be a dynamic month in hepatology, marked by notable advances across research, clinical practice, and public awareness.
Obinutuzumab Reduces Urinary Biomarkers of Lupus in Phase 2 NOBILITY Analysis

3 weeks ago | hcplive.com | Patrick Campbell |Abigail Brooks

A secondary analysis of the NOBILITY trial is offering clinicians further insight into the safety and efficacy of obinutuzumab (Gazya/Gazyvaro) among patients with lupus nephritis (LN).
Gyre Therapeutics' Hydronidone Meets Primary Endpoint in Phase 3 Hepatitis B Trial

3 weeks ago | contagionlive.com | Abigail Brooks

Hydronidone met the primary endpoint in a pivotal phase 3 trial evaluating its efficacy and safety for the treatment of liver fibrosis in patients with chronic hepatitis B (CHB) in China, according to a press release from Gyre Therapeutics.1The trial met its primary endpoint for ≥1-stage regression in liver fibrosis compared to placebo.
Conference Recap: 6 Key Trials From American Thoracic Society 2025

1 month ago | hcplive.com | Abigail Brooks

The American Thoracic Society’s (ATS) International Conference took place in San Francisco, California, from May 18-21, 2025. Coined as the home of pulmonary, critical care, and sleep professionals, the 4-day conference featured the latest advances in each of these spaces, including updates on key topics in asthma, chronic obstructive pulmonary disease (COPD), lung cancer, sepsis, acute respiratory distress, sleep apnea, and more.
FDA Accepts, Grants Priority Review to Sibeprenlimab BLA for IgA Nephropathy

1 month ago | hcplive.com | Abigail Brooks

The US Food and Drug Administration (FDA) has accepted and granted priority review to Otsuka Pharmaceutical Development & Commercialization’s Biologics License Application (BLA) for sibeprenlimab for the treatment of IgA nephropathy (IgAN).1Announced on May 27, 2025, the BLA acceptance is supported by data from the phase 3 VISIONARY trial, which met its primary endpoint at the prespecified interim analysis, as well as results from the Phase 2 ENVISION clinical trial.
Advocates wait for the results of Trump’s executive order on IVF policy

1 month ago | businessandamerica.com | Abigail Brooks

This week, Julie Eshelman has been holding her breath, waiting to see if President Donald Trump delivers on his campaign promise to make in vitro fertilization free. Eshelman is a military wife and, thanks to IVF, a mom. She first began fertility treatments in 2016, and she and her husband finally welcomed a baby girl — five years, several miscarriages and $80,000 later.